ReP USP - Resultado da busca

Artigo de periodico
HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents (2024)
Waitman, Karoline de Barros ; Almeida, Larissa Costa de ; Primi, Marina Candido ; Carlos, Jorge Antonio Elias Godoy ; Ruiz, Claudia; Kronenberger, Thales ; Laufer, Stefan; Goettert, Marcia Ines; Poso, Antti ; Vassiliades, Sandra Valeria ; Souza, Vinicius Albuquerque Moreira de ; Toledo, Mônica Franco Zannini Junqueira ; Hassimotto, Neuza Mariko Aymoto ; Cameron, Michael D; Bannister, Thomas D; Costa-Lotufo, Letícia Veras ; Machado Neto, João Agostinho ; Tavares, Maurício T.; Parise Filho, Roberto
Source: European Journal of Medicinal Chemistry. Unidades: FCF, ICB
Subjects: ANTINEOPLÁSICOS, HIBRIDIZAÇÃO, CÉLULAS CULTIVADAS DE TUMOR, PROTEÍNAS, PURINAS, CITOTOXINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WAITMAN, Karoline de Barros et al. HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents. European Journal of Medicinal Chemistry, v. 263, p. 1-18 art. 115935, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.ejmech.2023.115935. Acesso em: 14 nov. 2024.
APA
Waitman, K. de B., Almeida, L. C. de, Primi, M. C., Carlos, J. A. E. G., Ruiz, C., Kronenberger, T., et al. (2024). HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents. European Journal of Medicinal Chemistry, 263, 1-18 art. 115935. doi:10.1016/j.ejmech.2023.115935
NLM
Waitman K de B, Almeida LC de, Primi MC, Carlos JAEG, Ruiz C, Kronenberger T, Laufer S, Goettert MI, Poso A, Vassiliades SV, Souza VAM de, Toledo MFZJ, Hassimotto NMA, Cameron MD, Bannister TD, Costa-Lotufo LV, Machado Neto JA, Tavares MT, Parise Filho R. HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents [Internet]. European Journal of Medicinal Chemistry. 2024 ; 263 1-18 art. 115935.[citado 2024 nov. 14 ] Available from: https://dx.doi.org/10.1016/j.ejmech.2023.115935
Vancouver
Waitman K de B, Almeida LC de, Primi MC, Carlos JAEG, Ruiz C, Kronenberger T, Laufer S, Goettert MI, Poso A, Vassiliades SV, Souza VAM de, Toledo MFZJ, Hassimotto NMA, Cameron MD, Bannister TD, Costa-Lotufo LV, Machado Neto JA, Tavares MT, Parise Filho R. HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents [Internet]. European Journal of Medicinal Chemistry. 2024 ; 263 1-18 art. 115935.[citado 2024 nov. 14 ] Available from: https://dx.doi.org/10.1016/j.ejmech.2023.115935
Artigo de periodico
Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease (2023)
Rezende Junior, Celso de Oliveira ; Martinez, Pablo David Grigol; Ferreira, Rafael Augusto Alves; Koovits, Paul John ; Soares, Bruna Miranda ; Ferreira, Leonardo Luiz Gomes ; Duarte, Simone Michelan ; Chelucci, Rafael Consolin; Andricopulo, Adriano Defini ; Matheeussen, An ; Van Pelt, Natascha; Caljon, Guy ; Maes, Louis ; Campbell, Simon; Kratz, Jadel Muller ; Mowbray, Charles E. ; Dias, Luiz Carlos
Source: European Journal of Medicinal Chemistry. Unidade: IFSC
Subjects: DOENÇA DE CHAGAS, PLANEJAMENTO DE FÁRMACOS, TRYPANOSOMA CRUZI
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REZENDE JUNIOR, Celso de Oliveira et al. Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease. European Journal of Medicinal Chemistry, v. 246, n. Ja 2023, p. 114925-1-114925-10 + supplementary data, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.ejmech.2022.114925. Acesso em: 14 nov. 2024.
APA
Rezende Junior, C. de O., Martinez, P. D. G., Ferreira, R. A. A., Koovits, P. J., Soares, B. M., Ferreira, L. L. G., et al. (2023). Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease. European Journal of Medicinal Chemistry, 246( Ja 2023), 114925-1-114925-10 + supplementary data. doi:10.1016/j.ejmech.2022.114925
NLM
Rezende Junior C de O, Martinez PDG, Ferreira RAA, Koovits PJ, Soares BM, Ferreira LLG, Duarte SM, Chelucci RC, Andricopulo AD, Matheeussen A, Van Pelt N, Caljon G, Maes L, Campbell S, Kratz JM, Mowbray CE, Dias LC. Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease [Internet]. European Journal of Medicinal Chemistry. 2023 ; 246( Ja 2023): 114925-1-114925-10 + supplementary data.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.ejmech.2022.114925
Vancouver
Rezende Junior C de O, Martinez PDG, Ferreira RAA, Koovits PJ, Soares BM, Ferreira LLG, Duarte SM, Chelucci RC, Andricopulo AD, Matheeussen A, Van Pelt N, Caljon G, Maes L, Campbell S, Kratz JM, Mowbray CE, Dias LC. Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease [Internet]. European Journal of Medicinal Chemistry. 2023 ; 246( Ja 2023): 114925-1-114925-10 + supplementary data.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.ejmech.2022.114925
Artigo de periodico
Synthesis and investigation of the trypanocidal potential of novel 1,2,3-triazole-selenide hybrids (2022)
Chipoline, Ingrid C.; Brasil, Beatrice F. A; S. Neto, José S.; Valli, Marilia; Andricopulo, Renata Krogh; Cenci, Arthur R.; Teixeira, Kerolain F.; Zapp, Eduardo; Brondani, Daniela; Ferreira, Leonardo Luiz Gomes ; Andricopulo, Adriano Defini ; Oliveira, Aldo S.; Nascimento, Vanessa
Source: European Journal of Medicinal Chemistry. Unidade: IFSC
Subjects: DOENÇA DE CHAGAS, TRIPANOSSOMICIDAS, TRYPANOSOMA CRUZI
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHIPOLINE, Ingrid C. et al. Synthesis and investigation of the trypanocidal potential of novel 1,2,3-triazole-selenide hybrids. European Journal of Medicinal Chemistry, v. 243, p. 114687-1-114687-9, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.ejmech.2022.114687. Acesso em: 14 nov. 2024.
APA
Chipoline, I. C., Brasil, B. F. A., S. Neto, J. S., Valli, M., Andricopulo, R. K., Cenci, A. R., et al. (2022). Synthesis and investigation of the trypanocidal potential of novel 1,2,3-triazole-selenide hybrids. European Journal of Medicinal Chemistry, 243, 114687-1-114687-9. doi:10.1016/j.ejmech.2022.114687
NLM
Chipoline IC, Brasil BFA, S. Neto JS, Valli M, Andricopulo RK, Cenci AR, Teixeira KF, Zapp E, Brondani D, Ferreira LLG, Andricopulo AD, Oliveira AS, Nascimento V. Synthesis and investigation of the trypanocidal potential of novel 1,2,3-triazole-selenide hybrids [Internet]. European Journal of Medicinal Chemistry. 2022 ; 243 114687-1-114687-9.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.ejmech.2022.114687
Vancouver
Chipoline IC, Brasil BFA, S. Neto JS, Valli M, Andricopulo RK, Cenci AR, Teixeira KF, Zapp E, Brondani D, Ferreira LLG, Andricopulo AD, Oliveira AS, Nascimento V. Synthesis and investigation of the trypanocidal potential of novel 1,2,3-triazole-selenide hybrids [Internet]. European Journal of Medicinal Chemistry. 2022 ; 243 114687-1-114687-9.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.ejmech.2022.114687
Artigo de periodico
Discovery of highly potent and selective antiparasitic new oxadiazole and hydroxy-oxindole small molecule hybrids (2020)
Fernandes, Fábio S.; Santos, Hugo; Conti, Caroline; Rodrigues Junior, Manoel T.; Zeoly, Lucas A.; Ferreira, Leonardo Luiz Gomes ; Andricopulo, Renata Krogh; Andricopulo, Adriano Defini ; Coelho, Fernando
Source: European Journal of Medicinal Chemistry. Unidade: IFSC
Subjects: ANTIPARASITÁRIOS, TRYPANOSOMA CRUZI, LEISHMANIA INFANTUM, DOENÇA DE CHAGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Fábio S. et al. Discovery of highly potent and selective antiparasitic new oxadiazole and hydroxy-oxindole small molecule hybrids. European Journal of Medicinal Chemistry, v. 201, p. 112418-1-112418-14, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.ejmech.2020.112418. Acesso em: 14 nov. 2024.
APA
Fernandes, F. S., Santos, H., Conti, C., Rodrigues Junior, M. T., Zeoly, L. A., Ferreira, L. L. G., et al. (2020). Discovery of highly potent and selective antiparasitic new oxadiazole and hydroxy-oxindole small molecule hybrids. European Journal of Medicinal Chemistry, 201, 112418-1-112418-14. doi:10.1016/j.ejmech.2020.112418
NLM
Fernandes FS, Santos H, Conti C, Rodrigues Junior MT, Zeoly LA, Ferreira LLG, Andricopulo RK, Andricopulo AD, Coelho F. Discovery of highly potent and selective antiparasitic new oxadiazole and hydroxy-oxindole small molecule hybrids [Internet]. European Journal of Medicinal Chemistry. 2020 ; 201 112418-1-112418-14.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.ejmech.2020.112418
Vancouver
Fernandes FS, Santos H, Conti C, Rodrigues Junior MT, Zeoly LA, Ferreira LLG, Andricopulo RK, Andricopulo AD, Coelho F. Discovery of highly potent and selective antiparasitic new oxadiazole and hydroxy-oxindole small molecule hybrids [Internet]. European Journal of Medicinal Chemistry. 2020 ; 201 112418-1-112418-14.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.ejmech.2020.112418
Artigo de periodico
Investigating the structure-activity relationships of N’-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against Trypanosoma cruzi to design novel active compounds (2018)
Palace-Berl, Fanny; Pasqualoto, Kerly Fernanda Mesquita; Zingales, Bianca ; Moraes, Carolina Borsoi; Bury, Mariana; Franco, Caio Haddad; Silva Neto, Adelson Lopes da; Murayama, João Sussumu; Nunes, Solange Lessa; Silva, Marcelo Nunes da; Tavares, Leoberto Costa
Source: European Journal of Medicinal Chemistry. Unidades: IQ, FCF
Subjects: TRYPANOSOMA CRUZI, DOENÇA DE CHAGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PALACE-BERL, Fanny et al. Investigating the structure-activity relationships of N’-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against Trypanosoma cruzi to design novel active compounds. European Journal of Medicinal Chemistry, v. 144, p. 29-40, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.ejmech.2017.12.011. Acesso em: 14 nov. 2024.
APA
Palace-Berl, F., Pasqualoto, K. F. M., Zingales, B., Moraes, C. B., Bury, M., Franco, C. H., et al. (2018). Investigating the structure-activity relationships of N’-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against Trypanosoma cruzi to design novel active compounds. European Journal of Medicinal Chemistry, 144, 29-40. doi:10.1016/j.ejmech.2017.12.011
NLM
Palace-Berl F, Pasqualoto KFM, Zingales B, Moraes CB, Bury M, Franco CH, Silva Neto AL da, Murayama JS, Nunes SL, Silva MN da, Tavares LC. Investigating the structure-activity relationships of N’-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against Trypanosoma cruzi to design novel active compounds [Internet]. European Journal of Medicinal Chemistry. 2018 ; 144 29-40.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.ejmech.2017.12.011
Vancouver
Palace-Berl F, Pasqualoto KFM, Zingales B, Moraes CB, Bury M, Franco CH, Silva Neto AL da, Murayama JS, Nunes SL, Silva MN da, Tavares LC. Investigating the structure-activity relationships of N’-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against Trypanosoma cruzi to design novel active compounds [Internet]. European Journal of Medicinal Chemistry. 2018 ; 144 29-40.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.ejmech.2017.12.011

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Grupo de pesquisa

Funding Agencies

Non normalized affiliation